{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:33:10Z","timestamp":1769207590966,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety (MFDS)","doi-asserted-by":"publisher","award":["11171MFDS352"],"award-info":[{"award-number":["11171MFDS352"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.virusres.2016.07.012","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T18:09:57Z","timestamp":1470334197000},"page":"190-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine"],"prefix":"10.1016","volume":"223","author":[{"given":"Byung-Chul","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do-Keun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hwa","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeonhee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Mi","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiYoung","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3019-0699","authenticated-orcid":false,"given":"Cheol-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Keun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2016.07.012_bib0005","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0264-410X(02)00772-7","article-title":"Establishment of an analyzing method for a Japanese encephalitis virus neutralization test in Vero cells","volume":"21","author":"Abe","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.virusres.2016.07.012_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7883\/yoken.JJID.2008.333","article-title":"Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004","volume":"61","author":"Arai","year":"2004","journal-title":"Jpn. J. Infect. Dis."},{"issue":"2\u20133","key":"10.1016\/j.virusres.2016.07.012_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0264-410X(00)00144-4","article-title":"Evaluation of the potency of BIKEN inactivated Japanese Encephalitis vaccine and DNA vaccines in an intracerebral Japanese Encephalitis virus challenge","volume":"15\u201319","author":"Ashok","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2016.07.012_bib0020","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biologicals.2007.07.001","article-title":"Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies","volume":"36","author":"Borges","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.virusres.2016.07.012_bib0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4269\/ajtmh.1998.58.389","article-title":"Neutralizing mechanism of a monoclonal antibody against Japanese encephalitis virus glycoprotein E","volume":"58","author":"Butrapet","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.virusres.2016.07.012_bib0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biologicals.2010.12.001","article-title":"The consistency approach for quality control of vaccines \u2212 a strategy to improve quality control and implement 3Rs","volume":"39","author":"De Mattia","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.virusres.2016.07.012_bib0035","series-title":"Emerging Infections 8","first-page":"93","article-title":"Japanese encephalitis prevention and control: advances, challenges, and new initiatives, 93","author":"Fischer","year":"2008"},{"key":"10.1016\/j.virusres.2016.07.012_bib0040","series-title":"Health Information for International Travel 2010","first-page":"74","article-title":"Japanese encephalitis, 74","author":"Fischer","year":"2009"},{"key":"10.1016\/j.virusres.2016.07.012_bib0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2007.10.005","article-title":"Does antiviral therapy have a role in the control of Japanese encephalitis?","volume":"78","author":"Gould","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2016.07.012_bib0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5099\/aj100200184","article-title":"Stability of freeze-dried inactivated Japanese encephalitis vaccine under different experimental conditions","volume":"2","author":"Gowal","year":"2010","journal-title":"Am. J. Biomed. Sci."},{"key":"10.1016\/j.virusres.2016.07.012_bib0055","first-page":"269","article-title":"Assuring the quality of vaccines: regulatory requirements for licensing and batch release","volume":"4","author":"Griffiths","year":"1996","journal-title":"Methods Mol. Med."},{"issue":"1","key":"10.1016\/j.virusres.2016.07.012_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12098-008-0003-z","article-title":"India achieves negligible case fatality due to Japanese encephalitis despite no vaccination: an outbreak investigation in 2004","volume":"75","author":"Gupta","year":"2008","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.virusres.2016.07.012_bib0065","series-title":"Vaccines","first-page":"311","article-title":"Japanese encephalitis vaccines, 311","author":"Halstead","year":"2008"},{"issue":"3","key":"10.1016\/j.virusres.2016.07.012_bib0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1586\/erv.11.7","article-title":"New Japanese encephalitis vaccines: alternatives to production in mouse brain","volume":"10","author":"Halstead","year":"2011","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virusres.2016.07.012_bib0075","first-page":"747","article-title":"Validation of alternative methods for the potency testing of vaccines","volume":"26","author":"Hendriksen","year":"1998","journal-title":"ATLA"},{"issue":"Suppl","key":"10.1016\/j.virusres.2016.07.012_bib0080","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/ilar.43.Suppl_1.S43","article-title":"Refinement, reduction, and replacement of animal use for regulatory testing: current best scientific practices for the evaluation of safety and potency of biologicals","volume":"43","author":"Hendriksen","year":"2002","journal-title":"ILAR J."},{"key":"10.1016\/j.virusres.2016.07.012_bib0085","series-title":"Proc. 6th World Congress on Alternatives & Animal Use in the Life Sciences","first-page":"575","article-title":"Three rs achievements in vaccinology. AATEX 14, special issue","author":"Hendriksen","year":"2007"},{"key":"10.1016\/j.virusres.2016.07.012_bib0090","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.provac.2011.10.004","article-title":"Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directions","author":"Isbrucker","year":"2011","journal-title":"Proced. Vaccinol."},{"key":"10.1016\/j.virusres.2016.07.012_bib0095","unstructured":"Ministry of Food and Drug Safety, 2011. Korean Biological Products Specification and Test Methods, 120\u2013121."},{"key":"10.1016\/j.virusres.2016.07.012_bib0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1348-0421.2012.00462.x","article-title":"Development of an in vitro antigen-detection test as an alternative method to the in vivo plaque reduction neutralization test for the quality control of Japanese encephalitis virus vaccine","volume":"56","author":"Kim","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.virusres.2016.07.012_bib0105","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","article-title":"The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes","volume":"73","author":"Konishi","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2016.07.012_bib0110","unstructured":"Ministry of Health and Welfare, 2006. Japanese Government. Minimum Requirements for Biological Products, 93\u201394."},{"key":"10.1016\/j.virusres.2016.07.012_bib0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pneurobio.2010.01.008","article-title":"Overview. japanese encephalitis","volume":"91","author":"Misra","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.virusres.2016.07.012_bib0120","first-page":"5","article-title":"A new formula for direct calculation of neutralizing antibody titer against Japanese encephalitis virus from plaque reduction rate on chick embryo tissue culture, 5","author":"Oya","year":"1967","journal-title":"In 2nd Report of Japanese Vaccine Research Commission"},{"key":"10.1016\/j.virusres.2016.07.012_bib0125","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.vaccine.2009.12.006","article-title":"Would an in vitro ELISA test be a suitable alternative potency method to the in vivo immunogenicity assay commonly used in the context of international Hepatitis A vaccines batch release?","volume":"28","author":"Poirier","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2016.07.012_bib0130","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.provac.2011.10.015","article-title":"International regulatory requirements for vaccine safety and potency testing: a WHO perspective","author":"Shin","year":"2011","journal-title":"Proced. Vaccinol."},{"key":"10.1016\/j.virusres.2016.07.012_bib0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.virusres.2016.07.012_bib0140","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01310993","article-title":"Antigenicity of Japanese encephalitis virus envelope glycoprotein V3 (E) and its cyanogen bromide cleaved fragments examined by monoclonal antibodies and Western blotting","volume":"96","author":"Srivastava","year":"1987","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virusres.2016.07.012_bib0145","series-title":"In WHO Expert Committee on Biological Standardization","article-title":"Guidelines for national authorities on quality assurance for biological products. annex 2 (WHO technical report series, No. 822)","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.virusres.2016.07.012_bib0150","series-title":"In WHO Expert Committee on Biological Standardization","article-title":"Requirements for japanese encephalitis vaccine (inactivated) for human use. thirty-eighth report, annex 6 (WHO technical report series No. 771)","author":"World Health Organization","year":"1998"},{"key":"10.1016\/j.virusres.2016.07.012_bib0155","first-page":"331","article-title":"Japanese encephalitis vaccines","volume":"81","author":"World Health Organization","year":"2006","journal-title":"Wkly Epidemiol. Rec."},{"key":"10.1016\/j.virusres.2016.07.012_bib0160","series-title":"58st Meeting of the WHO Expert Committee on Biological Standardization","article-title":"Proposed revision: recommendations for japanese encephalitis vaccine (inactivated) for human use","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.virusres.2016.07.012_bib0165","series-title":"61st Meeting of the WHO Expert Committee on Biological Standardization","article-title":"Guidelines for independent lot release of vaccines by regulatory authorities","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.virusres.2016.07.012_bib0170","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1586\/erv.09.69","article-title":"Japanese encephalitis: is there a need for a novel vaccine?","volume":"8","author":"Wilder-Smith","year":"2009","journal-title":"Expert Rev. Vaccines"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170216300636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170216300636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T14:03:46Z","timestamp":1692453826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170216300636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"alternative-id":["S0168170216300636"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2016.07.012","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2016.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}